COMMUNIQUÉS West-GlobeNewswire

VIVUS Reports First Quarter 2019 Financial Results
30/04/2019
Company to host conference call today at 4:30pm ET CAMPBELL, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), a specialty pharmaceutical company committed to the development and [...]
Scholar Rock Appoints Akshay Vaishnaw, M.D., Ph.D. to Its Board of Directors
30/04/2019
Timothy A. Springer, Ph.D. will transition to a scientific advisory role CAMBRIDGE, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company [...]
GenMark Diagnostics Reports First Quarter 2019 Results
30/04/2019
CARLSBAD, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the [...]
CB2 Insights Announces FY2018 Financial Results After Transformative Year
30/04/2019
CB2 Insights to Host Conference Call Wednesday, May 1 at 4pm Eastern TORONTO, April 30, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB:CBTOF) (“ CB2 ” or the “ Company ”), a leading data-analytics company [...]
Synthorx Reports First Quarter Financial Results
30/04/2019
SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics [...]
HTG Molecular Diagnostics to Announce First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9
30/04/2019
TUCSON, Ariz., April 30, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial [...]
Teladoc Health Reports First Quarter 2019 Results
30/04/2019
Year-over-year revenue grows 43% to $128.6 million and total visits increase 75% to 1,063,000 Issues 2019 second quarter guidance; reaffirms full-year expectations PURCHASE, NY, April 30, 2019 (GLOBE NEWSWIRE) -- [...]
GenMark Diagnostics Expands Commercial Team
30/04/2019
CARLSBAD, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it has expanded its [...]
Merit Medical to Present at Three Conferences in May
30/04/2019
SOUTH JORDAN, Utah, April 30, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]
Evolus Reports First Quarter 2019 Financial Results
30/04/2019
U.S. Sales Force Hired and Trained with U.S Launch of Jeuveau™ Imminent NEWPORT BEACH, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric [...]
Cara Therapeutics to Announce First Quarter 2019 Financial Results on May 7, 2019
30/04/2019
STAMFORD, Conn., April 30, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on the [...]
Collegium to Participate in Upcoming Investor Conferences
30/04/2019
STOUGHTON, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that [...]
Genesis HealthCare to Release First Quarter 2019 Results on May 9, 2019
30/04/2019
KENNETT SQUARE, Pa., April 30, 2019 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it expects to release its [...]
Editas Medicine to Host Conference Call Discussing First Quarter 2019 Results and Corporate Update
30/04/2019
CAMBRIDGE, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Tuesday, May 7, 2019, at 5: [...]
Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2019 Financial Results and Provide Corporate Update
30/04/2019
BURNABY, British Columbia, April 30, 2019 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2019 financial [...]
Entasis Therapeutics to Participate in the 5th Annual SunTrust Robinson Humphrey (STRH) Annual Life Sciences Summit
30/04/2019
WALTHAM, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]
NOTICE TO DISREGARD – Profile Solutions, Inc.
30/04/2019
SUNRISE, Fla., April 30, 2019 (GLOBE NEWSWIRE) -- We are advised by Profile Solutions, Inc. that journalists and other readers should disregard the news release, "PSIQ ANNOUNCES RESELLER AGREEMENT WITH SHOPCBD.COM TO [...]
Immuron CEO Dr. Gary S. Jacob to Present at the ThinkEquity Conference on May 2, 2019
30/04/2019
MELBOURNE, Australia, April 30, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immuno-therapeutics for the [...]
Adverum Biotechnologies Presents First Preclinical Data on Dosing Contralateral Eye with ADVM-022 Gene Therapy for Wet AMD at the ARVO 2019 Annual Meeting
30/04/2019
-- ADVM-022 Safely Administered Sequentially to the Second Eye in Preclinical Study -- MENLO PARK, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy [...]

Pages